Abstract
BackgroundPatients (pts) receiving immune checkpoint inhibitor (ICI) therapy can experience periods of prolonged disease control after treatment discontinuation. Previous studies have used treatment-free survival (TFS) to characterize this interval in...
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have